Albany, NY -- (SBWIRE) -- 09/14/2015 -- About oncology molecular diagnostics

The global oncology molecular diagnostics market to grow at a CAGR of 17.8% over the period 2014-2019.

Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.

Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.

Download Sample Copy of this Report at http://www.marketresearchreports.biz/sample/sample/357234

Covered in this report

The report covers the current scenario and the growth prospects of the global oncology molecular diagnostics market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostics assay kits and instruments for cancers, which include:

Breast
Colorectal
Prostate
Others (including lung and cervical cancers)

Global Oncology Molecular Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Explore All Medical Equipments Market Research Reports at http://www.marketresearchreports.biz/category/109

Key regions:
APAC
Europe
Latin America
MEA
North America

Key vendors:
Abbott Diagnostics
Becton, Dickinson and Company
QIAGEN
Roche Diagnostics

Other prominent vendors:
Agendia
Angsana Molecular and Diagnostics
Asuragen
Autogenomics
Beckman Coulter
bioMrieux
bioTheranostics (Formerly AviaraDx)
Cangen Biotechnologies
Cepheid
Diagnocure
Epigenomics
Eragen
EXACT Sciences
Exiqon
GeneNews
Genera Biosystems
Genomic Health
Genomix Biotech
Health Discovery
HTG Molecular
Hologic
Innogenetics
Intergenetics
Kreatech Holding
Myriad Genetics
Nanosphere
NorDiag
Nuvera Biosciences
OncoMethylome Sciences
Orion Genomics
Prediction Sciences
Predictive Biosciences
Rosetta Genomics
SensiGen
Source MDx
Vermillion

Market driver:
Increase in demand for personalized medicines
For a full, detailed list, view our report

Market challenge:
Ethical, privacy, and practical issues
For a full, detailed list, view our report

Market trend:
Advances in mass spectrometry
For a full, detailed list, view our report

Key questions answered in this report:
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Related Reports:

Europe Disposable medical rubber examination gloves Industry 2015 at http://www.marketresearchreports.biz/analysis/356904

United States Orthopedic Trauma Devices Industry 2015 at http://www.marketresearchreports.biz/analysis/356355

Global Kidney Stones Management Devices Industry 2015 at http://www.marketresearchreports.biz/analysis/356322

Contacts:
MarketResearchReports.biz
Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@marketresearchreports.biz
http://www.marketresearchreports.biz